Carlene Macmillan

Carlene MacMillan, MD is a prominent psychiatrist and healthcare entrepreneur with extensive experience in mental health treatment and advocacy. She was the founder and CEO of Brooklyn Minds from September 2016 to April 2022, when the practice was acquired by Curated Mental Health.5

Professional Background

Dr. MacMillan received her medical training at Harvard Medical School, graduating in 2009.4 She completed her adult psychiatry residency and child/adolescent fellowship at Massachusetts General Hospital and McLean Hospital.13

Current Roles

Currently, Dr. MacMillan serves as:

• Chief Medical Officer at Osmind, focusing on product, growth, and medical affairs3
• Co-founder of Fermata, a pioneering interventional psychiatry practice and clinical trial site in NYC3

Previous Positions

Prior to her current roles, Dr. MacMillan held several notable positions:

• Founder and CEO of Brooklyn Minds (2016-2022)5
• Medical Director of the Ellenhorn NYC Private Assertive Community Treatment Team3
• Attending physician on the Trauma and Dissociative Unit at McLean Hospital3
• Faculty member at NYU Langone School of Medicine2

Expertise and Advocacy

Dr. MacMillan specializes in:

• Adult, adolescent, and child psychiatry4
• Treatment-resistant mental health conditions2
• Interventional psychiatry approaches, including TMS and psychedelic medicine3

She is actively involved in advocacy efforts, serving on several committees:

• Board of Directors and co-chair of the Insurance Committee for Clinical TMS Society3
• Co-Chair of the American Academy of Child and Adolescent Psychiatry Consumer Issues Committee2
• Board member of the Ketamine Taskforce for Access to Safe Care and Insurance Coverage4

Innovation and Thought Leadership

Dr. MacMillan is known for:

• Pioneering team-based and tech-enabled mental health care1
• Advocating for increased insurance-based access to psychiatric services2
• Promoting innovative value-based care payment models2
• Championing evidence-based approaches and innovations in psychiatry through social media and public speaking engagements34